Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$995K Buy
35,448
+3,163
+10% +$84.2K 0.09% 177
2025
Q4
$804K Buy
32,285
+19,254
+148% +$486K 0.08% 195
2025
Q3
$332K Buy
13,031
+1,209
+10% +$29.8K 0.07% 177
2025
Q2
$287K Buy
11,822
+121
+1% +$2.82K 0.07% 177
2025
Q1
$297K Buy
11,701
+1,991
+21% +$52.1K 0.08% 157
2024
Q4
$258K Sell
9,710
-3,286
-25% -$89.1K 0.08% 161
2024
Q3
$376K Buy
12,996
+688
+6% +$20.1K 0.11% 136
2024
Q2
$344K Buy
12,308
+3,104
+34% +$85.5K 0.11% 132
2024
Q1
$255K Buy
+9,204
New +$255K 0.09% 148
2023
Q2
$320K Sell
8,713
-490
-5% -$19.1K 0.1% 145
2023
Q1
$376K Buy
+9,203
New +$397K 0.13% 122

Other funds holding PFE

Sentinus LLC's PFE Position: Q1 2026 in Review

Sentinus LLC increased its Pfizer (PFE) stake by 9.8% in Q1 2026, buying an estimated $84.2K and bringing the position to 35,448 shares worth $995K. The position accounts for 0.09% of the portfolio, ranked #177.

Sentinus LLC first reported a position in PFE in Q1 2023 and has held it in 11 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Sentinus LLC held 35,448 shares of Pfizer worth $995K as of Q1 2026.
  • Sentinus LLC bought 3,163 Pfizer shares in Q1 2026, an estimated $84.2K.
  • Pfizer made up 0.09% of Sentinus LLC's portfolio in Q1 2026, its #177 holding.
  • Sentinus LLC first reported a position in Pfizer in Q1 2023 and has held it in 11 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Sentinus LLC's 13F filing for Q1 2026, filed 6 May 2026.